📊 DHR Key Takeaways
Is Danaher Corp. /DE/ (DHR) a Good Investment?
Danaher demonstrates exceptional operational profitability with 60% gross margins and 22.6% operating margins, supported by a fortress balance sheet (0.35x debt/equity) and $1.1B free cash flow generation. However, stagnant growth (2.9% revenue, flat net income) combined with critically low returns on equity (1.9%) and assets (1.2%) indicate severe capital inefficiency—the company cannot generate meaningful returns from its $83.5B asset base.
Danaher shows high-quality fundamentals with strong gross margins, solid operating profitability, and excellent free cash flow generation. The balance sheet remains healthy with good liquidity, modest leverage, and very strong interest coverage, which supports resilience and capital flexibility. The main limitation is that revenue growth has not translated into stronger net income or EPS, so the story is financially strong but not currently high-growth.
Why Buy Danaher Corp. /DE/ Stock? DHR Key Strengths
- Exceptional gross margin of 60.3% demonstrates strong pricing power and operational excellence
- Fortress balance sheet with conservative leverage (0.35x debt/equity) and fortress-like interest coverage of 20.7x
- Strong free cash flow generation of $1.1B with 18.2% FCF margin, indicating cash-generative operations
- High-margin business model with 59.1% gross margin and 21.4% free cash flow margin
- Strong financial health with 1.87x current ratio, 0.35x debt-to-equity, and 72.2x interest coverage
- Robust cash generation with $6.42B operating cash flow and $5.26B free cash flow
DHR Stock Risks: Danaher Corp. /DE/ Investment Risks
- Critically low ROE of 1.9% and ROA of 1.2% reveal severe capital inefficiency and asset underutilization
- Stagnant growth trajectory with flat net income (0% YoY) and declining diluted EPS (-4.5% YoY) suggests mature/declining business phase
- Ongoing share dilution evident from declining EPS despite stable net income, destroying shareholder value without growth offset
- Net income was flat year over year and diluted EPS declined 4.5%, indicating limited earnings leverage
- ROE of 6.9% and ROA of 4.3% are relatively modest for a high-quality industrial and life sciences platform
- Top-line growth of 2.9% is positive but not strong enough yet to clearly reaccelerate profitability
Key Metrics to Watch
- Revenue growth acceleration—currently anemic at 2.9% YoY; inflection required
- Return on equity normalization—1.9% is unsustainably low; capital redeployment or major operational changes needed
- Operating cash flow sustainability and FCF yield—monitor if margins compress or capital intensity increases
- Operating margin and EPS growth
- Free cash flow conversion relative to revenue growth
Danaher Corp. /DE/ (DHR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Danaher Corp. /DE/ presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
DHR Profit Margin, ROE & Profitability Analysis
DHR vs Industrial Sector: How Danaher Corp. /DE/ Compares
How Danaher Corp. /DE/ compares to Industrial sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Danaher Corp. /DE/ Stock Overvalued? DHR Valuation Analysis 2026
Based on fundamental analysis, Danaher Corp. /DE/ has mixed fundamental signals relative to the Industrial sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Danaher Corp. /DE/ Balance Sheet: DHR Debt, Cash & Liquidity
DHR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Danaher Corp. /DE/'s revenue has declined by 17% over the 5-year period, indicating business contraction. The most recent EPS of $6.38 reflects profitable operations.
DHR Revenue Growth, EPS Growth & YoY Performance
DHR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $5.7B | $954.0M | $1.32 |
| Q3 2025 | $5.8B | $818.0M | $1.12 |
| Q2 2025 | $5.7B | $555.0M | $0.77 |
| Q1 2025 | $5.7B | $954.0M | $1.32 |
| Q3 2024 | $5.6B | $818.0M | $1.12 |
| Q2 2024 | $5.7B | $907.0M | $1.22 |
| Q1 2024 | $5.8B | $1.1B | $1.45 |
| Q3 2023 | $6.9B | $1.1B | $1.51 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Danaher Corp. /DE/ Dividends, Buybacks & Capital Allocation
DHR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Danaher Corp. /DE/ (CIK: 0000313616)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DHR
What is the AI rating for DHR?
Danaher Corp. /DE/ (DHR) has a Combined AI Rating of BUY from Claude (HOLD) and ChatGPT (BUY) with 75% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DHR's key strengths?
Claude: Exceptional gross margin of 60.3% demonstrates strong pricing power and operational excellence. Fortress balance sheet with conservative leverage (0.35x debt/equity) and fortress-like interest coverage of 20.7x. ChatGPT: High-margin business model with 59.1% gross margin and 21.4% free cash flow margin. Strong financial health with 1.87x current ratio, 0.35x debt-to-equity, and 72.2x interest coverage.
What are the risks of investing in DHR?
Claude: Critically low ROE of 1.9% and ROA of 1.2% reveal severe capital inefficiency and asset underutilization. Stagnant growth trajectory with flat net income (0% YoY) and declining diluted EPS (-4.5% YoY) suggests mature/declining business phase. ChatGPT: Net income was flat year over year and diluted EPS declined 4.5%, indicating limited earnings leverage. ROE of 6.9% and ROA of 4.3% are relatively modest for a high-quality industrial and life sciences platform.
What is DHR's revenue and growth?
Danaher Corp. /DE/ reported revenue of $6.0B.
Does DHR pay dividends?
Danaher Corp. /DE/ pays dividends, with $226.0M distributed to shareholders in the trailing twelve months.
Where can I find DHR SEC filings?
Official SEC filings for Danaher Corp. /DE/ (CIK: 0000313616) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DHR's EPS?
Danaher Corp. /DE/ has a diluted EPS of $1.45.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DHR a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Danaher Corp. /DE/ has a BUY rating with 75% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is DHR stock overvalued or undervalued?
Valuation metrics for DHR: ROE of 1.9% (sector avg: 15%), net margin of 17.3% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy DHR stock in 2026?
Our dual AI analysis gives Danaher Corp. /DE/ a combined BUY rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is DHR's free cash flow?
Danaher Corp. /DE/'s operating cash flow is $1.3B, with capital expenditures of $237.0M. FCF margin is 18.2%.
How does DHR compare to other Industrial stocks?
Vs Industrial sector averages: Net margin 17.3% (avg: 10%), ROE 1.9% (avg: 15%), current ratio 1.87 (avg: 1.8).